La Presse médicale.
Publisher:
Masson,. Paris : Elsevier Masson (2012)
Frequency: Twelve no. a year, 2006?-
Country: France
Language: fre
Start Year:1983 -
ISSN:
0755-4982 (Print)
2213-0276 (Electronic)
0755-4982 (Linking)
2213-0276 (Electronic)
0755-4982 (Linking)
Impact Factor
2.7
2022
| NLM ID: | 8302490 |
| (DNLM): | P24030000(s) |
| (OCoLC): | 09262901 |
| Coden: | PRMEEM |
| Classification: | W1 PR455 |
[Evaluation of intravenous immunotherapy with purified F(ab’)2 fragments (Viperfav)]. To assess early clinical and biological prognosis factors in viper envenomings, and assess efficacy of Viperfav immunotherapy. Viperfav contains purified F(ab')2 fragments of equine antibodies. Methods: A retrospective case review study of viper envenomings collected by two poison centers in France, treated or not treated by Viperfav, was conducted. Two hundred seven cases of viper bites including 119 moderate or severe envenomings (Grade II and III, recorded in adults and children and collected from 1992 to 1997 were included. Before treatment, clinical gradation and early biological severity...